PharmaSource: The External Manufacturing Community Essential intelligence for biopharma outsourcing leaders | Trusted by 50,000+ professionals | Subscribe TOP STORIES OXB Signs Gene Therapy Manufacturing Agreement with Plowshare Therapies Read More » Crown Bioscience Joins C-Path’s NAMs Developer Coalition to Advance Regulatory Acceptance of Human-Relevant CRO Preclinical Models Merck Opens €25 Million BioReliance Testing Facility in Germany J&J Spends Up to $750M to Restructure Drug Supply Chain Insilico Medicine and Bora Pharmaceuticals Form AI-Driven Drug Discovery Alliance OneSource Specialty Pharma Partners with Formycon to Manufacture Biosimilars 3 Things Biotechs Need Before Going Public in 2026 Bora Biologics Expands U.S. Manufacturing Platform with Rockville Site Charles River Laboratories Partners with Arovella Therapeutics for CAR-iNKT Therapy Cellares Partners with Sonoma Biotherapeutics to Automate Treg Cell Therapy Manufacturing HKeyBio Launches HKEY-AI-NAM-Bridge™ 1.0 to Close Evidence Gaps Between AI, NAMs, and In Vivo CRO Validation WuXi Biologics’ Hebei Facility Passes FDA Pre-License Inspection for Autoimmune Therapy Olon Doubles Production Capacity at Concord Manufacturing Facility NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients Axplora’s Leverkusen Site Earns Platinum EcoVadis Rating More news + insights Crown Bioscience Joins C-Path’s NAMs Developer Coalition to Advance Regulatory Acceptance of Human-Relevant CRO Preclinical Models Merck Opens €25 Million BioReliance Testing Facility in Germany J&J Spends Up to $750M to Restructure Drug Supply Chain PODCASTS How Polpharma Transferred 21 Products Across Five CDMOs Without Breaking Supply How Bayer Builds Lasting CDMO Partnerships Through Trust and Constructive Tension SPOTLIGHT Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success RESOURCES Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success UPCOMING EVENTS External Manufacturing Leaders Basel 2026 External Manufacturing Leaders Dublin 2026 CDMO Live Americas . October 20-21, Boston 2026 CDMO Live Europe 2027
Crown Bioscience Joins C-Path’s NAMs Developer Coalition to Advance Regulatory Acceptance of Human-Relevant CRO Preclinical Models
HKeyBio Launches HKEY-AI-NAM-Bridge™ 1.0 to Close Evidence Gaps Between AI, NAMs, and In Vivo CRO Validation
NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data
ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients
Crown Bioscience Joins C-Path’s NAMs Developer Coalition to Advance Regulatory Acceptance of Human-Relevant CRO Preclinical Models